stockrowAlzamend Neuro, Inc. (ALZN) vs Cerenome, Inc. (CNSY)
- Alzamend Neuro, Inc. ALZN 1.24 −4.62%
- Cerenome, Inc. CNSY 1.11 +44.16%
Alzamend Neuro, Inc. and Cerenome, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Cerenome, Inc. are of similar size ($6.3M and $5.9M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −620.7%) and the higher return on invested capital (0.00% vs −532.8%). Across the 13 metrics below, Alzamend Neuro, Inc. leads on 10 and Cerenome, Inc. on 3.
Valuation
Profitability
| Metric | ALZN | CNSY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.27% |
| Operating margin | 0.00% | (628.12%) | 0.00% |
| Net margin | 0.00% | (620.70%) | 0.00% |
| Free cash flow margin | 0.00% | (560.29%) | 0.00% |
| Return on equity | (163.23%) | (614.05%) | (50.82%) |
| Return on assets | (122.36%) | (214.01%) | (46.08%) |
| Return on invested capital | 0.00% | (532.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack